No headlines found.
No press releases found.
No news found.
The First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible before fees and expenses the price and yield of the NYSE Arca Biotechnology Index.
First Trust Nyse Arca Biotechnology trades on the ARCA stock market under the symbol FBT.
As of July 1, 2026, FBT stock price climbed to $249.58 with 26,269 million shares trading.
FBT has a beta of 0.63, meaning it tends to be less sensitive to market movements. FBT has a correlation of 0.14 to the broad based SPY ETF.
FBT has a market cap of $2.83 billion. This is considered a Mid Cap stock.
In the last 3 years, FBT traded as high as $250.03 and as low as $130.27.
FBT has outperformed the market in the last year with a price return of +54.7% while the SPY ETF gained +22.4%. FBT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +29.3% and +10.2%, respectively, while the SPY returned +18.7% and 0.0%, respectively.
FBT support price is $244.12 and resistance is $251.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBT shares will trade within this expected range on the day.
